HOME >> BIOLOGY >> NEWS
Fragile X brain synapses mostly undeveloped, researchers say

Views of normal brains and of those afflicted with Fragile X Mental Retardation Syndrome are coming into focus, and the contrast in synapse development is vividly clear, say researchers at the University of Illinois Beckman Institute for Advanced Science and Technology.

A big difference is in dendritic spines--projections from nerve cells through which many impulses make their synaptic connections. Normal brains have thick, well-developed spines; mostly long, narrow and undeveloped spines protrude from the nerve cells in Fragile X brains.

The apparatus for normal development exists in both brains, but the message carrier is not working in Fragile X brains, researchers William T. Greenough and Ivan Jeanne Weiler reported Aug. 25 at the Ninth Annual International Workshop on Fragile X Syndrome and X-Linked Mental Retardation in Strasbourg, France. In Boston, before traveling to Europe, Greenough received a Distinguished Scientific Contribution Award during the American Psychological Association annual convention for his research on the mechanisms underlying learning and memory.

When stimulated in early development, spines in normal brain tissue rapidly record the experience, generate protein, grow and mature, forming a characteristic thick, functional shape. Spines in Fragile X brains don't change or mature. The Fragile X mental retardation protein (FMRP) is not working, thus secondary protein synthesis necessary for maturation does not occur, the researchers reported.

Their work-- funded by the FRAXA Research Foundation and the National Institute of Child Health and Human Development-- involves experiments with mice and rats and examinations of autopsy samples of human Fragile X patients.

In May 1997, a team led by Greenough and Weiler reported that FMRP is produced at synapses of the brain. Genetic suppression of FMRP already was known to cause mental retardation. Fragile X Syndrome is the most common cause of genetically inherited ment
'"/>

Contact: Jim Barlow, Life Sciences Editor
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
7-Sep-1999


Page: 1 2

Related biology news :

1. Newly developed tool aids study of Fragile X syndrome
2. The Fragile X syndrome protein as RNA distribution hub
3. New NIST procedure seeks improved diagnosis of Fragile X syndrome
4. Understanding key protein in Fragile X syndrome
5. Emory University Fragile X Group Receives NIH Program Grant
6. Researchers Find Production Point Of Key Protein In Fragile X Syndrome
7. Trial shows which brain cancer patients benefit from temozolomide
8. Targeted therapy knocks out pediatric brain cancer in mice
9. New way to protect brain from stroke damage
10. Chemical signals health of brain cells Symposium
11. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its inaugural South CEO conference to be held ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... its technology driven portfolio of 3D porous titanium spinal implants with the expansion ... Ti3D implant offerings while more than tripling the number of cervical and lumbar ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... are adjusting to client demands for precision medicine products. The report, Lab ... $19 billion in 2018, the pharma/bio sector is the largest source of demand ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... 02, 2019 , ... Rapid Novor, Inc., the world's leader ... has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now home to ... company's continuous commitment to quality research and service offerings. , The ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and ... company focused on the development of therapies to treat central nervous system ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
(Date:9/17/2019)... , ... September 16, 2019 , ... ... via CNBC on Saturday, September 21st @11:00am ET. Check local listings for more ... Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to developing ...
Breaking Biology Technology:
Cached News: